Get started
Author

Ayush Praveen

ORCID: 0009-0001-1086-3948
Observed ORCID: 0009-0001-1086-3948
OpenAlex ID: A5068413106
Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023 · Anjali Yadav, Tanay Biswas, et al. · Cancer Research Communications · 17
Abstract 1542: MALAT1 ablation dismantles homologous recombination repair machinery and sensitizes castrate resistant prostate cancer cells to PARP inhibitor
2022 · Anjali Yadav, Tanay Biswas, et al. · Cancer Research · 3
Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer.
2022 · Anjali Yadav, Tanay Biswas, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 3
PDF
DKC1 promotes colorectal cancer progression and therapy resistance by dysregulating sphingolipid biosynthesis
2026 · Umar K. Khan, Ayush Goel, et al. · Nature Communications · 2
PDF
Abstract 6805: DKC1 promotes colorectal cancer progression and therapy resistance by dysregulating sphingolipid biosynthesis
2025 · Umar Khalid Khan, Ayush Goel, et al. · Cancer Research
Canonical WNT signaling-driven DKC1 dysregulates sphingolipid biosynthesis and drives colorectal cancer.
2023 · Bushra Ateeq, Shivansh Nigam, et al. · Research Square
PDF
Supplementary Figure S1 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023 · Anjali Yadav, Tanay Biswas, et al.
PDF
FIGURE 3 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023 · Anjali Yadav, Tanay Biswas, et al.
FIGURE 4 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023 · Anjali Yadav, Tanay Biswas, et al.
Supplementary Figure S5 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023 · Anjali Yadav, Tanay Biswas, et al.
PDF
FIGURE 1 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023 · Anjali Yadav, Tanay Biswas, et al.
Supplementary Table S2 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023 · Anjali Yadav, Tanay Biswas, et al.
Supplementary Figure S4 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023 · Anjali Yadav, Tanay Biswas, et al.
Supplementary Figure S1 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023 · Anjali Yadav, Tanay Biswas, et al.
FIGURE 7 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023 · Anjali Yadav, Tanay Biswas, et al.
FIGURE 2 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023 · Anjali Yadav, Tanay Biswas, et al.
Supplementary Table S1 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023 · Anjali Yadav, Tanay Biswas, et al.
FIGURE 1 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023 · Anjali Yadav, Tanay Biswas, et al.
Supplementary Methods from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023 · Anjali Yadav, Tanay Biswas, et al.
PDF
Supplementary Table S1 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023 · Anjali Yadav, Tanay Biswas, et al.
Supplementary Figure S2 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023 · Anjali Yadav, Tanay Biswas, et al.
PDF
Supplementary Figure S7 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023 · Anjali Yadav, Tanay Biswas, et al.
FIGURE 6 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023 · Anjali Yadav, Tanay Biswas, et al.
Supplementary Figure S6 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023 · Anjali Yadav, Tanay Biswas, et al.
Data from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
2023 · Anjali Yadav, Tanay Biswas, et al.
Works count: 54
Citation count: 25
H-index: 3
I10-index: 1
Year
Topic
Type